Thus, further investigation of the overlap between these markers and LYVE-1 was performed in both the normal mammary gland and in mammary tumors to evaluate the heterogeneity of tumor-associated LYVE-1+ macrophages. This evidence concerns the gene LYVE1 and breast cancer.